Navigation Links
Fatalism Keeps Many From Colon Cancer Screening

TUESDAY, Sept. 27 (HealthDay News) -- A fatalistic attitude contributes to low colorectal cancer screening rates among poorer people, even when the screening and cancer care are free, according to U.K. researchers.

The researchers analyzed data from a series of surveys of 529 adults, aged 60 to 69, and the study findings are slated for publication in the journal Cancer Epidemiology, Biomarkers and Prevention.

"In England, the screenings are free and the subsequent health treatments are free as well, yet people of lower socioeconomic status still do not get screened. We wanted to find out what else was going on," Anne Miles, a lecturer in psychology at the University of London, said in a journal news release.

She and her colleagues found that poorer people who felt that colorectal cancer screenings wouldn't help, or that they were going to die of cancer anyway, often ignored screening recommendations.

The surveys completed by the participants collected information about their economic status, self-rated health and rate of cancer fatalism. Researchers compared those findings to the rate of a colorectal cancer screening method called fecal occult blood testing.

Men and women with higher socioeconomic status, better self-rated health and lower cancer fatalism were 56 percent more likely to have a fecal occult blood test.

It might be possible to reduce cancer fatalism if it is properly identified in patients, Miles suggested in the news release.

"There is clearly something else going on here besides costs. We need to understand people's attitudes toward screening," she said. "If they think it won't help, they won't do it, even if it's free."

More information

The U.S. National Cancer Institute has more about colorectal cancer screening.

-- Robert Preidt

SOURCE: Cancer Epidemiology, Biomarkers and Prevention, news release, Sept. 27, 2011

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Depression After Cancer Keeps Some From Follow-Up Care
2. Penn researchers describe key molecule that keeps immune cell development on track
3. Number of Americans With Asthma Keeps Rising
4. Use of Dietary Supplements Keeps Climbing: CDC
5. A change of heart keeps bears healthy while hibernating
6. Membrane molecule keeps nerve impulses hopping
7. Viral protein mimic keeps immune system quiet
8. Distrust of Health System Keeps Black Males From Getting Care
9. Rate of Eating Disorders in Kids Keeps Rising
10. Special skin keeps fish species alive on land
11. Number of Obese Adults Keeps Rising, CDC Says
Post Your Comments:
Related Image:
Fatalism Keeps Many From Colon Cancer Screening
(Date:12/1/2015)... ... December 01, 2015 , ... December 1, 2015—Since the start ... scientific research and discoveries, leading us to better understand the disease’s behavior. Globally, ... affected by HIV/AIDS. Mediaplanet’s cross-platform edition of “World AIDS Day” provides insight on ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... amputations in the United States. Podiatrists are well aware that psychology-based patient non-compliance ... behaviors) are often catastrophic contributors to diseases of the diabetic foot. The ...
(Date:12/1/2015)... ... December 01, 2015 , ... Visage accelerates mobile imaging results ... subsidiary of Pro Medicus Ltd. (ASX: PME), has announced they are demonstrating new ... America (RSNA) 2015 annual meeting through December 3 in Chicago, Illinois, at Booth ...
(Date:12/1/2015)... MA (PRWEB) , ... December 01, 2015 , ... Lutronic, ... release of Clarity, the latest addition to the devices for sale in the United ... 755 nm Alexandrite and long-pulsed 1064 nm Nd:YAG lasers, into a single platform that ...
(Date:12/1/2015)... ... December 01, 2015 , ... PartnerTech , a leader ... leadership since 2008. Gary Bruce, President of PartnerTech North America, currently serves as ... significant amount of time in Sweden since joining PartnerTech based in Malmo, Sweden. ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... Dec. 1, 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... chronic pain, announced today that the company will present at ... December 1-3 at the Luxe Sunset Boulevard Hotel in ... CEO of Relmada Therapeutics, will present on Thursday, December 3, ... . Please register at least 10 minutes prior ...
(Date:12/1/2015)... , Dec. 1, 2015 CytRx Corporation (NASDAQ: ... specializing in oncology, today announced that it has reached ... pivotal global Phase 3 clinical trial of aldoxorubicin in ... originally estimated to be completed in Q1 2016. The Phase ... under a Special Protocol Assessment from the FDA at ...
(Date:12/1/2015)... , Dec. 1, 2015  Today, ... the launch of CareFront, a first-of-its-kind population health ... diagnosed with cancer. Designed to be built into ... cancer patients with resources for their care and ... program also offers tools to help patients understand ...
Breaking Medicine Technology: